透皮測試用於評估腎小球濾過率
PMA 核准號：P230019 · 2026-06-10
廣告
器材摘要
Transdermal test for Assessment of Glomerular Filtration Rate is the device name listed in this FDA 510(k) record. The listed applicant is Medibeacon, Inc.. It received FDA 510(k) clearance on 2026-06-10. The device is classified under product code SDK. It was reviewed by the GU advisory panel.
常見問題
What is the Transdermal test for Assessment of Glomerular Filtration Rate?
Transdermal test for Assessment of Glomerular Filtration Rate is a medical device that received FDA 510(k) clearance on 2026-06-10. The listed applicant is Medibeacon, Inc..
When did Transdermal test for Assessment of Glomerular Filtration Rate receive FDA 510(k) clearance?
The clearance date for Transdermal test for Assessment of Glomerular Filtration Rate can be found in the official FDA records.
Who is the listed applicant for Transdermal test for Assessment of Glomerular Filtration Rate?
The FDA 510(k) record lists Medibeacon, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Transdermal test for Assessment of Glomerular Filtration Rate?
The FDA product code for Transdermal test for Assessment of Glomerular Filtration Rate is SDK.
相關臨床試驗
相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係，請查閱連結的官方來源。
官方來源
在 FDA 資料庫中查看 →資料來源為 FDA Open API。如需最新且權威的資訊，請始終參閱官方記錄。
廣告